Preoperative carbohydrate drink,
does it really help with Attenuation of immediate postoperative insulin resistance?
research showsThe grade is C with 50 points. Two very small randomized studies found postoperative insulin-sensitivity reductions of roughly 16% to 26% with carbohydrate versus 37% to 49% with placebo or fasting. The differences were large, but the outcome was a glucose-clamp biomarker, the investigator groups overlapped substantially, and the evidence cannot be extended to infection, length of stay, or recovery.
ads claimThe regimen delivered 100 g the prior evening and 50 g two hours before anesthesia. Preserving a clamp measurement must be separated from claims of fewer complications or faster recovery.
Useful facts when choosing a product
- The regimen used 800 mL the prior evening and 400 mL two hours pre-anesthesia, totaling 150 g carbohydrate.
- The key endpoint was whole-body insulin sensitivity measured by a hyperinsulinemic normoglycemic clamp.
- Substantial investigator overlap prevents counting the studies as independent replication.
Chamgap Semantic Classification Code
Candidate index · review held
P.carbohydrate-drink-taken-the-evening-before-and-before-elective-surgery.procedural.attenuation-of-immediate-postoperative-insulin-resistance.reduce.placeboProcedures, devices and tests > carbohydrate drink taken the evening before and before elective surgery > Procedural > Attenuation of immediate postoperative insulin resistance > Reduction claim > Placebo
An automated migration candidate, not an issued permanent code; exact claim scope remains under review. This machine-generated migration candidate helps retrieval but is not a permanent assignment. The original verdict ID and URL remain authoritative.
What the research actually shows
Nygren 1999 randomized 16 hip-replacement patients to carbohydrate or placebo and separately compared 14 colorectal-surgery patients receiving carbohydrate or fasting. Soop 2001 double-blindly assigned 15 hip-replacement patients, 8 versus 7. Nygren, Soop, Thorell, and Ljungqvist overlap across the reports, so they are not independent replication. Funding and allocation concealment could not be confirmed in the accessible material.
Why this is classified as C (50)
The metabolic effect was at least medium by statistical convention, but only a surrogate was measured in tiny studies with overlapping investigators, giving C with 50 points.
Counterpoint. This applies to metabolic response in elective non-diabetic surgical patients; clinical recovery and diabetic safety are separate questions.
Rejudgment record. Cross-check applied — Cross-checked group sizes, dosing, clamp outcomes, author overlap, and reported effects in both original records
| Endpoint | S | Surrogate marker - laboratory or imaging measures |
| Replication | R1 | Single confirmatory trial |
| Independence | I1 | Mixed funding sources |
| Effect size | E+ | Meets the clinically important threshold |
Stored derived and displayed grades match; this is not a current recalculation or validity check (C).
Sub-claim grades by effect
This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.
| Effect (sub-claim) | Grade | Basis |
|---|---|---|
| Attenuation of immediate postoperative insulin resistance | C | Two small studies moved in the same metabolic direction. |
| Reduction in surgical complications | ? | The pivotal studies did not test clinical complications. |
Cross-check — AI research and Codex final gate
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Nygren J, Soop M, Thorell A, Sree Nair K, Ljungqvist O. 1999 | Randomized placebo-controlled hip component and carbohydrate-versus-fasting colorectal component | 16 hip patients, 8/8, and 14 colorectal patients, 7/7 | Funding not confirmed in accessible material | Change in clamp-measured insulin sensitivity | Hip -16% versus -37%; colorectal -26±8% versus -49±6% | Early small metabolic-outcome evidence |
| Soop M, Nygren J, Myrenfors P, Thorell A, Ljungqvist O. 2001 | Double-blind randomized placebo-controlled trial | 15 participants, 8/7 | Funding not confirmed in accessible material | Immediate postoperative clamp-measured insulin sensitivity | -18% versus -43%, P<0.05 | Small confirmatory trial with overlapping investigators |
Receipt — 2 References
All 2 cited sources were verified for existence at the original page (as of 2026-08-15).
Final verification and publication gate: Codex · Evidence date: 2026-08-15 · Corrections: none
Cite this verdict
[Chamgap] Preoperative carbohydrate drink x postoperative insulin resistance — Evidence Grade C·50. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/blood-sugar/preoperative-carbohydrate-drink-postoperative-insulin-resistance/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.